LOVE.TO · Cannara Biotech Inc.
Canada · RS rating 87 · As of 2026-10-14
| Price | 2.08 CAD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 84 / 81 / 68 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 54 / 31 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +17.1% |
| Distance from 52-week high | +5.9% |
| Market cap (USD) | $144.4M |